Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients.
|
30352407 |
2018 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
To further investigate the role of SDHD and SDHB in the development of these tumours we determined the occurrence of germline SDHD and SDHB mutations in four patients with a family history of phaeochromocytoma with associated head and neck paraganglioma, one patient with a family history of phaeochromocytoma only and two patients with apparently sporadic extra-adrenal phaeochromocytoma, one of whom had early onset disease.
|
12618761 |
2003 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Only SDHD and SDHB have so far been implicated in the pathogenesis of pheochromocytoma.
|
15883706 |
2005 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Recently, nuclear genes encoding two mitochondrial complex II subunit proteins, SDHD and SDHB, have been found to be associated with the development of familial pheochromocytomas and paragangliomas (hereditary pheochromocytoma/paraganglioma syndrome: HPPS).
|
18362451 |
2008 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
The present findings for the first time demonstrate a significantly increased succinate-to-fumarate ratio in SDHB/D-related PGLs and thus suggest this ratio may be used as a new metabolic marker for the detection of SDHB/D-related PHEOs/PGLs.
|
24189137 |
2014 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Human genetic studies have now shown that 25-30% of patients have hereditary PH due to a germline mutation in the SDHB, SDHD, VHL, RET or NF1 gene and that the identification of a germline SDHB mutation is associated with a high risk of malignancy and a poor prognosis in PH/PGL patients.3.
|
18307724 |
2008 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A germline SDHD frameshift mutation was identified in a two-generation family consisting of four children with phaeochromocytoma, but somatic mutations were not detected in 24 sporadic phaeochromocytoma tumours.
|
11323050 |
2001 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This editorial summarizes some of these advances: the identification of the AIP, and the PDE11A and PDE8B genes by genome-wide association (GWA) studies as predisposing genes for pituitary and adrenal tumours, respectively, the discovery of p27 mutations in a new form of MEN similar to MEN type 1 (MEN 1) that is now known as MEN 4, the molecular investigations of Carney triad (CT), a disorder that associates paragangliomas (PGLs), gastrointestinal stromal tumour (GISTs), and pulmonary chondromas (PCH) with pheochromocytomas and adrenocortical adenomas and other lesions, and the molecular elucidation of the association of GISTs with paragangliomas (Carney-Stratakis syndrome) that is now known to be because of SDHB, SDHC, and SDHD mutations.
|
19522821 |
2009 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we explore the underlying molecular basis of three cases of paraganglioma or pheochromocytoma that came to our attention due to apparent maternal transmission of an SDHD mutation.
|
25300370 |
2014 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
|
25405498 |
2015 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Allelic losses of the SDHB gene were present in two phaeochromocytoma and one insulinoma cases and allelic losses of SDHD were present in one phaeochromocytoma case.
|
18510707 |
2008 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
|
31492822 |
2020 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Succinate dehydrogenase complex, subunit D (SDHD) mutations cause pheochromocytoma/paraganglioma syndrome.
|
23493432 |
2013 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas and pheochromocytomas and have been associated with germline heterozygous mutations in MAX, SDHA, SDHAF2, SDHB, SDHC, SDHD, or TMEM127.
|
31705439 |
2019 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Up to 30% of pheochromocytomas and paragangliomas are associated with germline RET, Von Hippel-Lindau (VHL), neurofibromatosis type I (NF1), and succinate dehydrogenase subunits (SDHB, SDHC, and SDHD) mutations.
|
20236688 |
2010 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A G12S variant of the SDHD gene was found in one patient affected by a PHEO.
|
17102085 |
2006 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations.
|
11404820 |
2001 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Germline mutations in four genes (RET, VHL, SDHB and SDHD) are detected in about 17% of patients with apparently sporadic pheochromocytoma.
|
22946750 |
2013 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
SDHB, SDHC, and SDHD molecular screening is important in all HNPs, with or without primary indicators of paraganglioma syndrome, to orient mutation-driven clinical screening for additional HNPs and pheochromocytoma.
|
17102086 |
2006 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Polymerase chain reaction of all exons of VHL, SDHB, and SDHD genes was performed on leukocyte DNA extracted from stored blood samples of 74 unrelated patients treated for pheochromocytoma.
|
19215943 |
2009 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In this study, both the risk of paraganglioma and phaeochromocytoma formation, and the risk of developing associated symptoms were investigated in 243 family members with the SDHD.D92Y founder mutation.
|
19584903 |
2010 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to determine whether SDHB and SDHD gene mutations in patients with pheochromocytoma/paraganglioma could be determined using a salivary sample.
|
26916530 |
2016 |
Pheochromocytoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Mutations in VHL, RET, NF1, SDHB, SDHC, and SDHD can give rise to pheochromocytoma/paraganglioma.
|
16098460 |
2005 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations in Von Hippel-Lindau (VHL), succinate dehydrogenase subunit B (SDHB), SDHC, and SDHD have been detected in individuals with synchronous or metachronous pheochromocytoma/paraganglioma (PHEO/PGL) and renal cell carcinoma (RCC).
|
25800244 |
2015 |
Pheochromocytoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Multifocal Paraganglioma and Pheochromocytoma Due to Truncated SDHD Mutation.
|
29545045 |
2018 |